About GPN Vaccines
GPN Vaccines is a private company based in Wilmington, Delaware, incorporated in 2025 in Delaware. It has reported $3,500,000 raised in one offering on Form D since January 2026. Its chief executive is Timothy Hirst.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 24, 2025 | Jan 28, 2026 | $3,500,000of $10.0M target | 63 | $55,556 | Equity, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GPN Vaccines's Form D filed Jan 28, 2026.

Timothy Hirst
Chairman and CEO

Sources
- SECGPN VACCINES, INC. filing history
- CompanyContact GPN Vaccines
- CompanyAbout GPN Vaccines
- CompanyBoard changes
- CompanyR&D tax incentive refund
- PressVaccine program update
